MyFinsight
Home
Blog
About
Cash and cash
equivalents, end of year
$15,174,128
(56.93%↑ Y/Y)
Prepaid expense,
current
$1,807,461
(36.19%↑ Y/Y)
Total current assets
$16,981,589
(54.42%↑ Y/Y)
Restricted cash,
noncurrent
$10,017,412
Operating lease,
right-of-use asset
$117,184
(-46.98%↓ Y/Y)
Accumulated deficit
-$85,007,966
(-111.56%↓ Y/Y)
Assets
$27,116,185
(127.21%↑ Y/Y)
Equity, attributable to
parent
-$1,763,651
Common stock, value,
issued
$74,298,513
(96.38%↑ Y/Y)
Additional paid-in capital
$8,884,707
(58.74%↑ Y/Y)
Accumulated other
comprehensive income (loss),...
$61,095
Total liabilities and
shareholders' deficit
$27,116,185
(127.21%↑ Y/Y)
Ending balance
-$1,724,964
(-153.10%↓ Y/Y)
Equity, attributable to
noncontrolling interest
$38,687
Total liabilities
$28,841,149
(232.04%↑ Y/Y)
Secured long-term debt,
noncurrent
$17,982,542
Liabilities, current
$10,841,493
(26.89%↑ Y/Y)
Loans payable,
noncurrent
$17,114
Accounts payable,
current
$6,734,310
(280.43%↑ Y/Y)
Secured debt, current
$3,500,000
Accrued and other
accounts payable
$308,007
(-83.15%↓ Y/Y)
Represents the related
party payable
$161,846
(33.46%↑ Y/Y)
Operating lease,
liability, current
$137,330
(10.39%↑ Y/Y)
Back
Back
Balance Sheet
Medicus Pharma Ltd. (MDCXW)
Medicus Pharma Ltd. (MDCXW)
source: myfinsight.com